Although cannabis and all its parts are considered in Israel as dangerous drugs, government support for cannabis start-ups and liberal policies with regard to research have helped the country to develop an active cannabis industry.
The domestic Israeli CBD market remains restricted, but the country can contribute to the global CBD sector in other ways, such as research and farming, according to Saul Kaye, CEO of cannabis technology and medical research firm ICann.
Currently, cannabis and its derivatives are only available through prescription. And while the law has allowed doctors to prescribe it for patients, it hasn’t allowed the market to flourish yet across the board. Overall CBD, is still considered to be like THC.
“That will ideally change,” Kaye told CBD-Intel. “We are hoping for new legislation around CBD so it will be regulated completely separately.”...